Drug Profile
Research programme: cyclo-oxygenase-2/cyclo-oxygenase-1 inhibitors - Simulations Plus
Latest Information Update: 26 Mar 2014
Price :
$50
*
At a glance
- Originator Simulations Plus
- Class Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Suspended Inflammation; Pain; Rheumatic disorders
Most Recent Events
- 26 Mar 2014 Suspended for Inflammation in USA (unspecified route)
- 26 Mar 2014 Suspended for Pain in USA (unspecified route)
- 26 Mar 2014 Suspended for Rheumatic disorders in USA (unspecified route)